发明名称 Glycerophospholipids for the improvement of cognitive functions
摘要 The invention described herein provides a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates with a specific content and specific conjugation patterns of LA, linolenic acid (alpha-linolenic acid, gamma-linolenic acid) DHA and EPA which depend on utilizing different sources of lipids, and uses of such preparations.
申请公布号 US9168310(B2) 申请公布日期 2015.10.27
申请号 US201314063401 申请日期 2013.10.25
申请人 ENZYMOTEC LTD. 发明人 Ben Dror Gai;Platt Dorit;Farkash Orly;Zuabi Rassan;Bar-On Zohar;Shulman Avidor;Pelled Dori;Richter Yael
分类号 A23D9/013;A23L1/30;A61K31/66;A61K31/685;A61K47/48;C07F9/10;A21D2/32;A23D7/01 主分类号 A23D9/013
代理机构 Cooper & Dunham LLP 代理人 White John P.;Cooper & Dunham LLP
主权项 1. A method of improving a condition in an elderly subject with a disorder involving impaired cognitive performance which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, wherein the mixture comprises (a) linoleic acid (C18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w % of (a)/the w/w % of (b) is from about 0.09 to about 3.6 and the w/w % of (a)/w/w % of (f) is from about 0.23 to about 9.4, and wherein the disorder is selected from the group consisting of cognitive impairment no dementia, pre-Alzheimer's disease, pre-dementia syndrome, age related cognitive decline, cognitive deterioration and any combination of two or more of such disorders.
地址 Migdal Haemeq IL